Literature DB >> 22855844

Ligand-induced MET signaling as targetable codependence in acute myeloid leukemia.

Stefan Fröhling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22855844      PMCID： PMC3409806          DOI： 10.3324/haematol.2012.073635

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  11 in total

Review 1.  Use of RNA interference libraries to investigate oncogenic signalling in mammalian cells.

Authors:  Julian Downward
Journal:  Oncogene       Date:  2004-11-01       Impact factor: 9.867

2.  RNAi screen for therapeutic target in leukemia.

Authors:  Jeffrey Tyner; Brian J Druker
Journal:  Cell Cycle       Date:  2009-07-15       Impact factor: 4.534

3.  A loss-of-function RNA interference screen for molecular targets in cancer.

Authors:  Vu N Ngo; R Eric Davis; Laurence Lamy; Xin Yu; Hong Zhao; Georg Lenz; Lloyd T Lam; Sandeep Dave; Liming Yang; John Powell; Louis M Staudt
Journal:  Nature       Date:  2006-03-29       Impact factor: 49.962

4.  FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo.

Authors:  Takashi Sato; Xiaochuan Yang; Steven Knapper; Paul White; B Douglas Smith; Steven Galkin; Donald Small; Alan Burnett; Mark Levis
Journal:  Blood       Date:  2011-01-24       Impact factor: 22.113

5.  Effect of hepatocyte growth factor on early human haemopoietic cell development.

Authors:  M Z Ratajczak; W Marlicz; J Ratajczak; M Wasik; B Machalinski; A Carter; A M Gewirtz
Journal:  Br J Haematol       Date:  1997-10       Impact factor: 6.998

6.  Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells.

Authors:  Claudia Scholl; Stefan Fröhling; Ian F Dunn; Anna C Schinzel; David A Barbie; So Young Kim; Serena J Silver; Pablo Tamayo; Raymond C Wadlow; Sridhar Ramaswamy; Konstanze Döhner; Lars Bullinger; Peter Sandy; Jesse S Boehm; David E Root; Tyler Jacks; William C Hahn; D Gary Gilliland
Journal:  Cell       Date:  2009-05-29       Impact factor: 41.582

Review 7.  Deregulation of signaling pathways in acute myeloid leukemia.

Authors:  Claudia Scholl; D Gary Gilliland; Stefan Fröhling
Journal:  Semin Oncol       Date:  2008-08       Impact factor: 4.929

8.  Principles of cancer therapy: oncogene and non-oncogene addiction.

Authors:  Ji Luo; Nicole L Solimini; Stephen J Elledge
Journal:  Cell       Date:  2009-03-06       Impact factor: 41.582

9.  RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.

Authors:  Johannes Zuber; Junwei Shi; Eric Wang; Amy R Rappaport; Harald Herrmann; Edward A Sison; Daniel Magoon; Jun Qi; Katharina Blatt; Mark Wunderlich; Meredith J Taylor; Christopher Johns; Agustin Chicas; James C Mulloy; Scott C Kogan; Patrick Brown; Peter Valent; James E Bradner; Scott W Lowe; Christopher R Vakoc
Journal:  Nature       Date:  2011-08-03       Impact factor: 49.962

10.  Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia.

Authors:  Alex Kentsis; Casie Reed; Kim L Rice; Takaomi Sanda; Scott J Rodig; Eleni Tholouli; Amanda Christie; Peter J M Valk; Ruud Delwel; Vu Ngo; Jeffery L Kutok; Suzanne E Dahlberg; Lisa A Moreau; Richard J Byers; James G Christensen; George Vande Woude; Jonathan D Licht; Andrew L Kung; Louis M Staudt; A Thomas Look
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.